The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed

McDonnell, 1987, Molecular cloning of complementary DNA encoding the avian receptor for vitamin D, Science, 235, 1214, 10.1126/science.3029866

Haussler, 1988, Molecular biology of the vitamin D hormone, Recent Prog Horm Res, 44, 263

Evans, 1988, The steroid and thyroid hormone receptor superfamily, Science, 240, 889, 10.1126/science.3283939

Holick, 1996, Vitamin D and bone health, J Nutr, 126, 1159S, 10.1093/jn/126.suppl_4.1159S

MacDonald, 1994, New insight into the structure and functions of the vitamin D receptor, Sem Nephrol, 14, 101

Haussler, 1977, Basic and clinical concepts related to vitamin D metabolism and action, N Engl J Med, 297, 1041, 10.1056/NEJM197711102971906

Labuda, 1992, Two hereditary defects related to vitamin D metabolism map to the same region of human chromosome 12q13–14, J Bone Miner Res, 7, 1447, 10.1002/jbmr.5650071212

St-Arnaud, 1997, The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus, J Bone Miner Res, 12, 1552, 10.1359/jbmr.1997.12.10.1552

Takeyama, 1997, 25-hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis, Science, 277, 1827, 10.1126/science.277.5333.1827

Rut, 1994, Two mutations causing vitamin D resistant rickets: Modelling on the basis of steroid hormone receptor DNA-binding domain crystal structures, Clin Endocrinol, 41, 581, 10.1111/j.1365-2265.1994.tb01822.x

Whitfield, 1996, Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: Point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner, Mol Endocrinol, 10, 1617

Haussler, 1997, The vitamin D hormone and its nuclear receptor: Molecular actions and disease states, J Endocrinol, 154, S57

Malloy, 1997, Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness, J Clin Invest, 99, 297, 10.1172/JCI119158

Hewison, 1993, Tissue resistance to 1,25-dihydroxyvitamin D without a mutation of the vitamin D receptor gene, Clin Endocrinol, 39, 663, 10.1111/j.1365-2265.1993.tb02424.x

Giraldo, 1995, Vitamin D dependent rickets type II and normal vitamin D receptor cDNA sequence. A cluster in a rural area of Cauca, Colombia, with more than 200 affected children, Clin Genet, 48, 57, 10.1111/j.1399-0004.1995.tb04056.x

Yoshizawa, 1997, Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning, Nat Genet, 16, 391, 10.1038/ng0897-391

Li, 1997, Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia, Proc Natl Acad Sci USA, 94, 9831, 10.1073/pnas.94.18.9831

Li, 1997, Cloning and characterization of the vitamin D receptor from Xenopus laevis, Endocrinology, 138, 2347, 10.1210/endo.138.6.5210

Li, 1997, Vitamin D receptor knock-out mice develop hypocalcemia, hyperparathyroidism, rickets, osteomalacia and alopecia, J Bone Miner Res, 12, S123 (abstract 81)

Balsan, 1986, Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D, J Clin Invest, 77, 1661, 10.1172/JCI112483

al-Aqeel, 1993, The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII), Clin Endocrinol (Oxf), 39, 229, 10.1111/j.1365-2265.1993.tb01779.x

Takeda, 1997, Bone metabolism and in vitro osteoclast formation in VDR knock-out mice, J Bone Miner Res, 12, S110 (abstract 32)

Jimi, 1996, Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact, Endocrinology, 137, 2187, 10.1210/endo.137.5.8612568

Henry, 1992, Vitamin D hydroxylases, J Cellular Biochem, 49, 4, 10.1002/jcb.240490103

Brumbaugh, 1975, Cytoplasmic and nuclear binding components for 1α,25-dihydroxyvitamin D3 in chick parathyroid glands, Proc Natl Acad Sci USA, 72, 4871, 10.1073/pnas.72.12.4871

Hughes, 1975, Regulation of serum 1α,25-dihydroxyvitamin D3 by calcium and phosphate in the rat, Science, 190, 578, 10.1126/science.1188357

Silver, 1985, Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells, Proc Natl Acad Sci USA, 82, 4270, 10.1073/pnas.82.12.4270

Sugimoto, 1989, Combined effects of dexamethasone and 1,25-dihydroxyvitamin D3 on parathyroid hormone secretion in cultured bovine parathyroid cells, Endocrinology, 125, 638, 10.1210/endo-125-2-638

Mackey, 1996, Vitamin D receptor binding to the negative human parathyroid hormone vitamin D response element does not require the retinoid X receptor, Mol Endocrinol, 10, 298

Reddy, 1989, Calcitroic acid, end product of renal metabolism of 1,25-dihydroxyvitamin D3 through C-24 oxidation pathway, Biochemistry, 28, 1763, 10.1021/bi00430a051

Tomon, 1990, 1,25-dihydroxyvitamin D3-inducible catabolism of vitamin D metabolites in mouse intestine, Am J Physiol, 258, G557

Haussler, 1982, Vitamin D, Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism, 109

Ohyama, 1994, Identification of a vitamin D-responsive element in the 5′ flanking region of the rat 25-hydroxyvitamin D3 24-hydroxylase gene, J Biol Chem, 269, 10545, 10.1016/S0021-9258(17)34094-2

St-Arnaud, 1997, Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone, 635

Henry, 1978, Vitamin D: Two dihydroxylated metabolites are required for normal chicken egg hatchability, Science, 201, 835, 10.1126/science.684411

Nakamura, 1988, Increase of bone volume in vitamin D-repleted rats by massive administration of 24R,25(OH)2D3, Calcif Tissue Int, 43, 235, 10.1007/BF02555140

Schwartz, 1995, Treatment of resting zone chondrocytes with 24,25-dihydroxyvitamin D3[24,25-(OH)2D3] induces differentiation into a 1,25-(OH)2D3–responsive phenotype characteristic of growth zone chondrocytes, Endocrinology, 136, 402, 10.1210/endo.136.2.7530645

Seino, 1997, Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone, 640

DeMay, 1992, Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3, Proc Natl Acad Sci USA, 89, 8097, 10.1073/pnas.89.17.8097

Tenenhouse, 1997, Cellular and molecular mechanisms of renal phosphate transport, J Bone Miner Res, 12, 159, 10.1359/jbmr.1997.12.2.159

Taketani, 1997, Gene structure and functional analysis of the human Na+/phosphate co-transporter, Biochem J, 324, 927, 10.1042/bj3240927

Drezner, 1980, Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia, J Clin Invest, 66, 1020, 10.1172/JCI109930

Harrel, 1985, Healing of bone disease in X-linked hypohosphatemic rickets/osteomalacia: Induction and maintenance with phosphorus and calcitriol, J Clin Invest, 75, 1858, 10.1172/JCI111900

Francis, 1995, A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets, Nat Genet, 11, 130, 10.1038/ng1095-130

Parker, 1981, Tumor-induced osteomalacia: Evidence for a surgically correctable alteration in vitamin D metabolism, J Am Med Assoc, 245, 492, 10.1001/jama.1981.03310300046018

Nesbitt, 1992, Crosstransplantation of kidneys in normal and hyp-mice: Evidence that the hyp-mouse phenotype is unrelated to an intrinsic renal defect, J Clin Invest, 89, 1453, 10.1172/JCI115735

Meyer, 1989, Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice, J Bone Miner Res, 4, 493, 10.1002/jbmr.5650040407

Econs, 1994, Tumor-induced osteomalacia—Unveiling a new hormone, N Engl J Med, 330, 1679, 10.1056/NEJM199406093302310

Cai, 1994, Inhibition of renal phosphate transport by a tumor product in a patient with oncogeneic osteomalacia, N Engl J Med, 330, 1645, 10.1056/NEJM199406093302304

Rowe, 1996, The gene for X-linked hypohosphataemic rickets maps to a 200–300 kb region in Xp22.1, and is located on a single YAC containing a putative vitamin D response element (VDRE), Hum Genet, 97, 345, 10.1007/BF02185769

Quesada, 1990, Effect of calcitriol on insulin secretion in uraemia, Nephrol Dial Transplant, 5, 1013, 10.1093/ndt/5.12.1013

Smith, 1988, A novel approach for the evaluation and treatment of psoriasis: Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis, J Am Acad Dermatol, 19, 516, 10.1016/S0190-9622(88)70207-8

Manolagas, 1994, Vitamin D and the hematolymphopoietic tissue: A 1994 update, Sem Nephrol, 14, 129

Casteels, 1995, Immunomodulatory effects of 1,25-dihydroxyvitamin D3, Curr Opin Nephrol Hypertens, 4, 313, 10.1097/00041552-199507000-00005

Wientroub, 1989, Effect of vitamin D deficiency on macrophage and lymphocyte function in the rat, Calcif Tissue Int, 44, 125, 10.1007/BF02556471

Lemire, 1992, The vitamin D3 analogue 1,25-dihydroxy-Δ16-cholecalciferol prolongs the survival of murine cardiac allografts, Transplantation, 54, 762, 10.1097/00007890-199210000-00046

Lemire, 1995, Immunomodulatory actions of 1,25-dihydroxyvitamin D3, J Steroid Biochem Mol Biol, 53, 599, 10.1016/0960-0760(95)00106-A

Reitsma, 1983, Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite, Nature, 306, 492, 10.1038/306492a0

Mangelsdorf, 1984, 1,25-dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): Receptor-mediated maturation to macrophage-like cells, J Cell Biol, 98, 391, 10.1083/jcb.98.2.391

Branisteanu, 1995, Prevention of murine experimental allergic encephalomyelitis: Cooperative effects of cyclosporine and 1 alpha,25-(OH)2D3, J Neuroimmunol, 61, 151, 10.1016/0165-5728(95)00076-E

Nataf, 1996, 1,25-dihydroxyvitamin D3 exerts regional effects in the central nervous system during experimental allergic encephalomyelitis, J Neuropathol Exp Neurol, 55, 904, 10.1097/00005072-199608000-00006

Naveilhan, 1996, 1,25-dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor, Neuroreport, 7, 2171, 10.1097/00001756-199609020-00023

Furman, 1996, Differential expression of M-CSF, LIF, and TNF-alpha genes in normal and malignant rat glial cells: Regulation by lipopolysaccharide and vitamin D, J Neurosci Res, 46, 360, 10.1002/(SICI)1097-4547(19961101)46:3<360::AID-JNR9>3.0.CO;2-I

Neveu, 1994, 1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes, Neuroreport, 6, 124, 10.1097/00001756-199412300-00032

Neveu, 1994, 1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells, Brain Res, 24, 70

Saporito, 1994, Chronic 1,25-dihydroxyvitamin D3-mediated induction of nerve growth factor mRNA and protein in L929 fibroblasts and in adult rat brain, Brain Res, 633, 189, 10.1016/0006-8993(94)91539-3

Sonnenberg, 1986, 1,25-Dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei, Endocrinology, 118, 1433, 10.1210/endo-118-4-1433

Dowd, 1992, Stable expression of the calbindin-D28K complementary DNA interferes with the apoptotic pathway in lymphocytes, Mol Endocrinol, 6, 1843

Airaksinen, 1997, Ataxia and altered dendritic calcium signaling in mice carrying a targeted null mutation of the calbindin D28k gene, Proc Natl Acad Sci USA, 94, 1488, 10.1073/pnas.94.4.1488

Sutherland, 1992, Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: Correlation with calbindin-D28k mRNA levels, Brain Res Mol Brain Res, 13, 239, 10.1016/0169-328X(92)90032-7

Maguire-Zeiss, 1995, Calbindin-D28k mRNA in hippocampus, superior temporal gyrus and cerebellum: Comparison between control and Alzheimer disease subjects, Brain Res Mol Brain Res, 30, 362, 10.1016/0169-328X(95)00035-Q

Miyamoto, 1997, Structural organization of the human vitamin D receptor chromosomal gene and its promoter, Mol Endocrinol, 11, 1165, 10.1210/mend.11.8.9951

Faraco, 1989, ApaI dimorphism at the human vitamin D receptor gene locus, Nucleic Acids Res, 17, 2150, 10.1093/nar/17.5.2150

Laudet, 1991, Genomic organization of the human thyroid hormone receptor α (c-erbA-1) gene, Nucleic Acids Res, 19, 1105, 10.1093/nar/19.5.1105

Morrison, 1994, Prediction of bone density from vitamin D receptor alleles, Nature, 367, 284, 10.1038/367284a0

Morrison, 1997, Prediction of bone density from vitamin D receptor alleles [correction], Nature, 387, 106, 10.1038/387106a0

Riggs, 1995, The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women, J Bone Miner Res, 10, 991, 10.1002/jbmr.5650100622

Fleet, 1995, The BsmI vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women, J Bone Miner Res, 10, 985, 10.1002/jbmr.5650100621

Hustmyer, 1994, Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus, J Clin Invest, 94, 2130, 10.1172/JCI117568

Barger-Lux, 1995, Vitamin D receptor gene polymorphism, bone mass, body size, and vitamin D receptor density, Calcif Tissue Int, 57, 161, 10.1007/BF00298438

Lim, 1995, Lack of association between vitamin D receptor genotypes and osteoporosis in Koreans, J Clin Endocrinol Metab, 80, 3677, 10.1210/jcem.80.12.8530619

Garnero, 1995, Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenopausal women, J Bone Miner Res, 10, 1283, 10.1002/jbmr.5650100902

Houston, 1996, Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture: Studies in a UK population, Bone, 18, 249, 10.1016/8756-3282(95)00483-1

Cooper, 1996, Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis, J Bone Miner Res, 11, 1841, 10.1002/jbmr.5650111203

Ferrari, 1995, Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density [see comments], Lancet, 345, 423, 10.1016/S0140-6736(95)90404-2

Salamone, 1996, The association between vitamin D receptor gene polymorphisms and bone mineral density at the spine, hip and whole-body in premenopausal women, Osteoporos Int, 6, 63, 10.1007/BF01626540

Viitanen, 1996, Common polymorphism of the vitamin D receptor gene is associated with variation of peak bone mass in young Finns, Calcif Tissue Int, 59, 231, 10.1007/s002239900113

McClure, 1997, Vitamin D receptor polymorphisms, bone mineral density, and bone metabolism in postmenopausal Mexican-American women, J Bone Miner Res, 12, 234, 10.1359/jbmr.1997.12.2.234

Feldman, 1997, Androgen and vitamin D receptor gene polymorphisms: The long and short of prostate cancer risk, J Natl Cancer Inst, 89, 109, 10.1093/jnci/89.2.109

Carling, 1997, Vitamin D receptor alleles b, a, and T: Risk factors for sporadic primary hyperparathyroidism (HPT) but not HPT of uremia or MEN 1, Biochem Biophys Res Commun, 231, 329, 10.1006/bbrc.1997.6086

Taylor, 1996, Association of prostate cancer with vitamin D receptor gene polymorphism, Cancer Res, 56, 4108

Ingles, 1997, Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: Implications for association studies, Cancer Epidemiol Biomarkers Prev, 6, 93

Ingles, 1997, Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor, J Natl Cancer Inst, 89, 166, 10.1093/jnci/89.2.166

Ingles, 1997, Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone, 813

Karran, 1996, Microsatellite instability and DNA mismatch repair in human cancer, Semin Cancer Biol, 7, 15, 10.1006/scbi.1996.0003

Arai, 1997, A vitamin D receptor gene polymorphism in the translation initiation codon: Effect on protein activity and relation to bone mineral density in Japanese women, J Bone Miner Res, 12, 915, 10.1359/jbmr.1997.12.6.915

Gross, 1996, The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women, J Bone Miner Res, 11, 1850, 10.1002/jbmr.5650111204

Witte, 1997, The short or ‘F’ form of the vitamin D receptor appears to be of recent evolutionary origin and unique to humans, J Bone Miner Res, 12, S371 (abstract F579)

MacDonald, 1993, Retinoid X receptors stimulate and 9-cis retinoic acid inhibits, 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene, Mol Cell Biol, 13, 5907

Cockerill, 1997, Mutations in the vitamin D receptor gene in three kindreds associated with hereditary vitamin D resistant rickets, J Clin Endocrinol Metab, 82, 3156, 10.1210/jcem.82.9.4243

Hawa, 1996, Identification of a novel mutation in hereditary vitamin D resistant rickets causing exon skipping, Clin Endocrinol, 45, 85, 10.1111/j.1365-2265.1996.tb02064.x

Rastinejad, 1995, Structural determinants of nuclear receptor assembly on DNA direct repeats, Nature, 375, 203, 10.1038/375203a0

Hsieh, 1998

Hsieh, 1991, Human vitamin D receptor is selectively phosphorylated by protein kinase C on serine 51, a residue crucial to its trans-activation function, Proc Natl Acad Sci USA, 88, 9315, 10.1073/pnas.88.20.9315

Hsieh, 1993, Phosphorylation of the human vitamin D receptor by protein kinase C: Biochemical and functional evaluation of the serine 51 recognition site, J Biol Chem, 268, 15118, 10.1016/S0021-9258(18)82445-0

Walters, 1980, Unoccupied 1,25-dihydroxyvitamin D3 receptors, J Biol Chem, 255, 6799, 10.1016/S0021-9258(18)43643-5

Clemens, 1988, Immunocytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells, Endocrinology, 122, 1224, 10.1210/endo-122-4-1224

Berger, 1988, Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues, J Clin Endocrinol Metab, 67, 607, 10.1210/jcem-67-3-607

Milde, 1989, Immunohistochemical detection of 1,25-dihydroxyvitamin D3 receptors and estrogen receptors by monoclonal antibodies: Comparison of four immunoperoxidase methods, J Histochem Cytochem, 37, 1609, 10.1177/37.11.2553800

Zanello, 1997, Vitamin D receptor expression in chicken muscle tissue and cultured myoblasts, Horm Metab Res, 29, 231, 10.1055/s-2007-979027

Luo, 1994, A peptide C-terminal to the second Zn finger of human vitamin D receptor is able to specify nuclear localization, Eur J Biochem, 223, 381, 10.1111/j.1432-1033.1994.tb19004.x

Simental, 1991, Transcriptional activation and nuclear targeting signals of the human androgen receptor, J Biol Chem, 266, 510, 10.1016/S0021-9258(18)52466-2

Guiochon-Mantel, 1989, Mechanisms of nuclear localization of the progesterone receptor: Evidence for interaction between monomers, Cell, 57, 1147, 10.1016/0092-8674(89)90052-4

Picard, 1987, Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor, EMBO J, 6, 3333, 10.1002/j.1460-2075.1987.tb02654.x

Barsony, 1997, Subcellular distribution of normal and mutant vitamin D receptors in living cells, J Biol Chem, 272, 5774, 10.1074/jbc.272.9.5774

Saijo, 1991, A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin D-dependent rickets type II: Utility of single stranded conformation polymorphism analysis for heterozygous carrier detection, Am J Hum Genet, 49, 668

Sackey, 1996, Determinants of subcellular distribution of the glucocorticoid receptor, Mol Endocrinol, 10, 1191

Renaud, 1995, Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid, Nature, 378, 681, 10.1038/378681a0

Wagner, 1995, A structural role for hormone in the thyroid hormone receptor, Nature, 378, 690, 10.1038/378690a0

Bourguet, 1995, Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α, Nature, 375, 377, 10.1038/375377a0

Kristjansson, 1993, Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25-dihydroxyvitamin D3, J Clin Invest, 92, 12, 10.1172/JCI116539

Jones, 1991, Vitamin D receptor phosphorylation in transfected ROS 17/2.8 cells is localized to the N-terminal region of the hormone-binding domain, Mol Endocrinol, 5, 1137, 10.1210/mend-5-8-1137

Nakajima, 1996, Examination of the potential functional role of conserved cysteine residues in the hormone binding domain of the human 1,25-dihydroxyvitamin D3 receptor, J Biol Chem, 271, 5143, 10.1074/jbc.271.9.5143

Nakajima, 1994, The C-terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D responsive element, Mol Endocrinol, 8, 159

Wurtz, 1997, Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone, 165

Nishikawa, 1995, Vitamin D receptor contains multiple dimerization interfaces that are functionally different, Nucleic Acids Res, 23, 606, 10.1093/nar/23.4.606

Hsieh, 1995, The T-box near the zinc fingers of the human vitamin D receptor is required for heterodimeric DNA binding and transactivation, Biochem Biophys Res Commun, 215, 1, 10.1006/bbrc.1995.2426

Rosen, 1993, Dimerization interfaces of thyroid hormone, retinoic acid, vitamin D, and retinoid X receptors, J Biol Chem, 268, 11534, 10.1016/S0021-9258(19)50233-2

Whitfield, 1995, A highly conserved region in the hormone binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation, Mol Endocrinol, 9, 1166

Jin, 1996, Transcriptional activation and dimerization functions in the human vitamin D receptor, Mol Endocrinol, 10, 945

Henttu, 1997, AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors, Mol Cell Biol, 17, 1832, 10.1128/MCB.17.4.1832

Webster, 1988, The hormone binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function, Cell, 54, 199, 10.1016/0092-8674(88)90552-1

Danielian, 1992, Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors, EMBO J, 11, 1025, 10.1002/j.1460-2075.1992.tb05141.x

Saatcioglu, 1993, A novel cis element mediating ligand-independent activation by c-ErbA: Implications for hormonal regulation, Cell, 75, 1095, 10.1016/0092-8674(93)90319-L

Leng, 1995, Mouse retinoid X receptor contains a separable ligand-binding and transactivation domain in its E region, Mol Cell Biol, 15, 255, 10.1128/MCB.15.1.255

Jurutka, 1997, Mutations in the 1,25-dihydroxyvitamin D3 receptor identifying C-terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding and interaction with basal transcription factor IIB, in vitro, J Biol Chem, 272, 14592, 10.1074/jbc.272.23.14592

Masuyama, 1997, Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction, Mol Endocrinol, 11, 1507, 10.1210/mend.11.10.9990

Haussler, 1997, Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone, 210

Haussler, 1994, Vitamin D: A Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Applications, 209

Brown, 1990, Phosphorylation of the 1,25-dihydroxyvitamin D3 receptor: A primary event in 1,25-dihydroxyvitamin D3 action, J Biol Chem, 265, 10025, 10.1016/S0021-9258(19)38773-3

Jurutka, 1993, Phosphorylation of the human, 1,25-dihydroxyvitamin D3 receptor by cAMP-dependent protein kinase, in vitro, and in transfected COS-7 cells, Biochem Biophys Res Commun, 191, 1089, 10.1006/bbrc.1993.1328

Nakajima, 1996, Effects of cyclic adenosine monophosphate and protein kinase-A on ligand-dependent transactivation via vitamin D receptor, J Bone Miner Res, 11, S162 (abstract P287)

Jurutka, 1993, Phosphorylation of serine 208 in the human vitamin D receptor: The predominant amino acid phosphorylated by casein kinase II, in vitro, and identification as a significant phosphorylation site in intact cells, J Biol Chem, 268, 6791, 10.1016/S0021-9258(18)53319-6

Hilliard, 1994, 1,25-Dihydroxyvitamin D3 modulates phosphorylation of serine 205 in the human vitamin D receptor: Site-directed mutagenesis of this residue promotes alternative phosphorylation, Biochemistry, 33, 4300, 10.1021/bi00180a026

Jurutka, 1996, Human vitamin D receptor phosphorylation by casein kinase II at ser-208 potentiates transcriptional activation, Proc Natl Acad Sci USA, 93, 3519, 10.1073/pnas.93.8.3519

Taneja, 1997, Phosphorylation of activation functions AF-1 and AF-2 of RARalpha and RARgamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment, EMBO J, 16, 6452, 10.1093/emboj/16.21.6452

Baker, 1988, Cloning and expression of full-length cDNA encoding human vitamin D receptor, Proc Natl Acad Sci USA, 85, 3294, 10.1073/pnas.85.10.3294

Burmester, 1988, Structure and regulation of the rat 1,25-dihydroxyvitamin D3 receptor, Proc Natl Acad Sci USA, 85, 9499, 10.1073/pnas.85.24.9499

Kamei, 1995, Cloning and sequencing of the gene encoding the mouse vitamin D receptor, Gene, 152, 281, 10.1016/0378-1119(94)00735-B

Haussler, 1988, Progress in Endocrinology, 763

Lu, 1997, Cloning and origin of the two forms of chicken vitamin D receptor, Arch Biochem Biophys, 339, 99, 10.1006/abbi.1996.9864

Colnot, 1995, Identification of DNA sequences that bind retinoid X receptor-1,25(OH)2D3-receptor heterodimers with high affinity, Mol Cell Endocrinol, 113, 89, 10.1016/0303-7207(95)03618-H

Nishikawa, 1994, Difference and similarity of DNA sequence recognized by VDR homodimer and VDR/RXR heterodimer, Nucleic Acids Res, 22, 2902, 10.1093/nar/22.15.2902

Jin, 1996, Human vitamin D receptor-dependent transactivation in Saccharomyces cerevisiae requires retinoid X receptor, Mol Endocrinol, 10, 196

MacDonald, 1991, Baculovirus-mediated expression of the human vitamin D receptor: Functional characterization, vitamin D response element interactions, and evidence for a receptor auxiliary factor, J Biol Chem, 266, 18808, 10.1016/S0021-9258(18)55135-8

Staal, 1996, Distinct conformations of vitamin D receptor/retinoid X receptor-α heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements for the osteocalcin and osteopontin genes, Mol Endocrinol, 10, 1444

O'Connell, 1995, 1,25-Dihydroxyvitamin D3 regulation of myocardial growth and c-myc levels in the rat heart, Biochem Biophys Res Commun, 213, 59, 10.1006/bbrc.1995.2098

Pan, 1997, Vitamin D: Chemistry, Biology and Clinical Application of the Steroid Hormone, 306

Alroy, 1995, Transcriptional repression of the interleukin-2 gene by vitamin D3: Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor, Mol Cell Biol, 15, 5789, 10.1128/MCB.15.10.5789

Breen, 1994, In vivo occupancy of the vitamin D responsive element in the osteocalcin gene supports vitamin D-dependent transcriptional upregulation in intact cells, Proc Natl Acad Sci USA, 91, 12902, 10.1073/pnas.91.26.12902

Koszewski, 1996, Turning a negative into a positive: Mutation of the avian parathyroid hormone response element and vitamin D transcriptional activity, J Bone Miner Res, 11, S115 (abstract 83)

Lian, 1997, Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: Dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression, Endocrinology, 138, 2117, 10.1210/endo.138.5.5117

Zhang, 1997, 1,25-dihydroxyvitamin D3 inhibits osteocalcin expression in mouse through an indirect mechanism, J Biol Chem, 272, 110, 10.1074/jbc.272.1.110

Kurokawa, 1995, Polarity-specific activities of retinoic acid receptors determined by a co-repressor, Nature, 377, 451, 10.1038/377451a0

Rowland-Goldsmith, 1997, Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone, 300

Forman, 1995, Unique response pathways are established by allosteric interactions among nuclear hormone receptors, Cell, 81, 541, 10.1016/0092-8674(95)90075-6

Chen, 1996, Two distinct actions of retinoid-receptor ligands, Nature, 382, 819, 10.1038/382819a0

Minucci, 1997, Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependant gene expression, Mol Cell Biol, 17, 644, 10.1128/MCB.17.2.644

Zugmaier, 1996, Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells, Br J Cancer, 73, 1341, 10.1038/bjc.1996.256

Kane, 1996, Antiproliferative responses of two human colon cancer cell lines to vitamin D3 are differentially modified by 9-cis-retinoic acid, Cancer Res, 56, 623

Kang, 1997, The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1,25-dihydroxyvitamin D3 in human skin in vivo, J Invest Dermatol, 108, 513, 10.1111/1523-1747.ep12289736

Li, 1997, Retinoid X receptor-specific ligands synergistically upregulate 1,25-dihydroxyvitamin D3-dependent transcription in epidermal keratinocytes in vitro and in vivo, J Invest Dermatol, 108, 506, 10.1111/1523-1747.ep12289733

Blutt, 1997, 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1, Endocrinology, 138, 1491, 10.1210/endo.138.4.5063

Carlberg, 1993, Two nuclear signalling pathways for vitamin D, Nature, 361, 657, 10.1038/361657a0

Lemon, 1996, Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo, Mol Cell Biol, 16, 1006, 10.1128/MCB.16.3.1006

Zou, 1997, Retinoid X receptor (RXR) ligands activate the human 25-hydroxyvitamin D3-24-hydroxylase promoter via RXR heterodimer binding to two vitamin D-responsive elements and elicit additive effects with 1,25-dihydroxyvitamin D3, J Biol Chem, 272, 19027, 10.1074/jbc.272.30.19027

Guo, 1997, YY1 regulates vitamin D receptor/retinoid X receptor mediated transactivation of the vitamin D responsive osteocalcin gene, Proc Natl Acad Sci USA, 94, 121, 10.1073/pnas.94.1.121

Liu, 1994, Transcriptional synergism between the vitamin D3 receptor and other nonreceptor transcription factors, Mol Endocrinol, 8, 1593

Candeliere, 1996, A composite element binding the vitamin D receptor, retinoid X receptor α, and a member of the CTF/NF-1 family of transcription factors mediates the vitamin D responsiveness of the c-fos promoter, Mol Cell Biol, 16, 584, 10.1128/MCB.16.2.584

Krause, 1997, Calreticulin, Cell, 88, 439, 10.1016/S0092-8674(00)81884-X

Chen, 1995, A transcriptional co-repressor that interacts with nuclear hormone receptors, Nature, 377, 454, 10.1038/377454a0

Perlmann, 1997, Nuclear receptors in Sicily: All in the famiglia, Cell, 90, 391, 10.1016/S0092-8674(00)80498-5

Horwitz, 1996, Nuclear receptor coactivators and corepressors, Mol Endocrinol, 10, 1167

Edmondson, 1996, Chromatin and transcription, FASEB J, 10, 1173, 10.1096/fasebj.10.10.8751719

Makino, 1997, SUG1, a component of the 26 S proteasome, is an ATPase stimulated by specific RNAs, J Biol Chem, 272, 23201, 10.1074/jbc.272.37.23201

Masuyama, 1997, Proteasome-mediated degradation of the vitamin D receptor (VDR) and the potential involvement of a 1,25-(OH)2D3–dependent interaction between the VDR AF-2 domain and SUG1, J Bone Miner Res, 12, S122 (abstract 79)

vom Baur, 1996, Differential ligand–dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1, EMBO J, 15, 110, 10.1002/j.1460-2075.1996.tb00339.x

Lemon, 1997, Retinoid X receptor:vitamin D3 receptor heterodimers promote stable preinitiation complex formation and direct 1,25-dihydroxyvitamin D3-dependent cell-free transcription, Mol Cell Biol, 17, 1923, 10.1128/MCB.17.4.1923

Brown, 1994, Selective vitamin D analogs and their therapeutic applications, Sem Nephrol, 14, 156

Bouillon, 1995, Structure-function relationships in the vitamin D endocrine system, Endocr Rev, 16, 200

Peleg, 1995, Distinct conformational changes induced by 20-epi analogues of 1α,25-dihydroxyvitamin D3 are associated with enhanced activation of the vitamin D receptor, J Biol Chem, 270, 10551, 10.1074/jbc.270.18.10551

Abe, 1989, A synthetic analogue of vitamin D3, 22-oxa-1α,25-dihydroxyvitamin D3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice, Endocrinology, 124, 2645, 10.1210/endo-124-5-2645

Brown, 1989, The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion, J Clin Invest, 84, 728, 10.1172/JCI114229

Cheskis, 1995, Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differentially affected by analogs of 1,25-dihydroxyvitamin D3, Mol Endocrinol, 9, 1814

Reichrath, 1997, Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin, J Am Acad Dermatol, 36, 19, 10.1016/S0190-9622(97)70320-7

Mehta, 1997, Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1α-hydroxyvitamin D5, J Natl Cancer Inst, 89, 212, 10.1093/jnci/89.3.212

van den Bemd, 1996, Conformational change and enhanced stabilization of the vitamin D receptor by the 1,25-dihydroxyvitamin D3 analog KH1060, Proc Natl Acad Sci USA, 93, 10685, 10.1073/pnas.93.20.10685

Liu, 1997, Differential interaction of 1alpha,25-dihydroxyvitamin D3 analogues and their 20-epi homologues with the vitamin D receptor, J Biol Chem, 272, 3336, 10.1074/jbc.272.6.3336

Zhao, 1997, Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system, Mol Endocrinol, 11, 366, 10.1210/mend.11.3.9895

Ishizuka, 1997, Novel 1α,25-dihydroxyvitamin D3-26,23-lactone analogues function as antagonists of vitamin D receptor-mediated genomic actions of 1α,25-dihydroxyvitamin D3, J Bone Miner Res, 12, S452 (abstract S399)

Ozono, 1997, Novel 1α,25-dihydroxyvitamin D3 analogue, TEI-9647, acts as an antagonist of the vitamin D receptor, J Bone Miner Res, 12, S122 (abstract 78)

Reichel, 1987, 1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes, Proc Natl Acad Sci USA, 84, 3385, 10.1073/pnas.84.10.3385

Barna, 1997, Effect of calcitriol on the production of T-cell-derived cytokines in psoriasis, Br J Dermatol, 136, 536, 10.1046/j.1365-2133.1997.d01-1231.x

Johnson, 1996, 1,25-dihydroxyvitamin D3 receptors in developing dorsal root ganglia of fetal rats, Brain Res Dev Brain Res, 92, 120, 10.1016/0165-3806(95)00204-9

Musiol, 1997, 1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: Effect of vitamin D3 analogs, Endocrinology, 116, 149

Rizk-Rabin, 1994, Synthesis of and response to 1,25 dihydroxycholecalciferol by subpopulations of murine epidermal keratinocytes: Existence of a paracrine system for 1,25 dihydroxycholecalciferol, J Cell Physiol, 159, 131, 10.1002/jcp.1041590117

Reichrath, 1994, Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle, Br J Dermatol, 131, 477, 10.1111/j.1365-2133.1994.tb08547.x

Johnson, 1996, Immunohistochemical detection and distribution of the 1,25-dihydroxyvitamin D3 receptor in rat reproductive tissues, Histochem Cell Biol, 105, 7, 10.1007/BF01450873

Peehl, 1994, Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells, Cancer Res, 54, 805

Giuliano, 1991, Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: Effect of cellular differentiation, Arch Biochem Biophys, 285, 261, 10.1016/0003-9861(91)90358-P

Bikle, 1993, Vitamin D, calcium and epidermal differentiation, Endocr Rev, 14, 3

Limat, 1993, Effects of 1 alpha,25-dihydroxy-vitamin D3 and calcipotriol on organotypic cultures of outer root sheath cells: A potential model to evaluate antipsoriatic drugs, Arch Dermatol Res, 285, 402, 10.1007/BF00372133

Narvaez, 1997, Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant, Endocrinology, 138, 4690, 10.1210/endo.138.11.5545

Thomas, 1992, Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line, Gut, 33, 1660, 10.1136/gut.33.12.1660

Nguyen, 1996, Evidence for a vitamin D paracrine system regulating maturation of developing rat lung epithelium, Am J Physiol, 271, L392

Stumpf, 1979, Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid, Science, 206, 1188, 10.1126/science.505004

Johnson, 1994, Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas, Am J Physiol, 267, E356

Atley, 1995, 1,25-dihydroxyvitamin D3-induced upregulation of the thyrotropin-releasing hormone receptor in clonal rat pituitary GH3 cells, J Endocrinol, 147, 397, 10.1677/joe.0.1470397

Berg, 1994, Vitamin D receptor binding and biological effects of cholecalciferol analogues in rat thyroid cells, J Steroid Biochem Mol Biol, 50, 145, 10.1016/0960-0760(94)90021-3

Dokoh, 1983, The ovary: A target organ for 1,25-dihydroxyvitamin D3, Endocrinology, 112, 200, 10.1210/endo-112-1-200

Bidmon, 1991, Vitamin D receptors in heart: Effects on atrial natriuretic factor, Experientia, 47, 958, 10.1007/BF01929891

Li, 1994, Negative regulation of the human atrial natriuretic peptide gene by 1,25-dihydroxyvitamin D3, J Biol Chem, 269, 4934, 10.1016/S0021-9258(17)37635-4

Wu, 1996, 1,25(OH)2 Vitamin D3 and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes, J Clin Invest, 97, 1577, 10.1172/JCI118582

Kawada, 1996, The possibility of active form of vitamins A and D as suppressors on adipocyte development via ligand-dependent transcriptional regulators, Int J Obes Relat Metab Disord, 20, S52

Vu, 1996, 1,25-dihydroxyvitamin D induces lipoprotein lipase expression in 3T3-L1 cells in association with adipocyte differentiation, Endocrinology, 137, 1540, 10.1210/endo.137.5.8612483

Hedlund, 1996, Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: Evidence that the antiproliferative effects of 1α,25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway, Endocrinology, 137, 1554, 10.1210/endo.137.5.8612485

Yabushita, 1996, Vitamin D receptor in endometrial carcinoma and the differentiation-inducing effect of 1,25-dihydroxyvitamin D3 on endometrial carcinoma cell lines, J Obstet Gynaecol Res, 22, 529, 10.1111/j.1447-0756.1996.tb01068.x

Liu, 1996, Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937, Genes Dev, 10, 142, 10.1101/gad.10.2.142

Kawa, 1997, Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines, Br J Cancer, 76, 884, 10.1038/bjc.1997.479

Rots, 1997, Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone, 423

Elstner, 1996, Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells, Cancer Res, 56, 3570

Simboli-Campbell, 1997, Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells, Breast Cancer Res Treat, 42, 31, 10.1023/A:1005772432465

DeMay, 1990, DNA sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D3 receptor and confer responsiveness to 1,25-dihydroxyvitamin D3, Proc Natl Acad Sci USA, 87, 369, 10.1073/pnas.87.1.369

Markose, 1990, Vitamin D-mediated modifications in protein–DNA interactions at two promoter elements of the osteocalcin gene, Proc Natl Acad Sci USA, 87, 1701, 10.1073/pnas.87.5.1701

Terpening, 1991, The vitamin D-responsive element in the rat bone gla protein is an imperfect direct repeat that cooperates with other cis-elements in 1,25-dihydroxyvitamin D3-mediated transcriptional activation, Mol Endocrinol, 5, 373, 10.1210/mend-5-3-373

Kerner, 1989, Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3, Proc Natl Acad Sci USA, 86, 4455, 10.1073/pnas.86.12.4455

Morrison, 1989, 1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene, Science, 246, 1158, 10.1126/science.2588000

Ozono, 1990, The vitamin D-responsive element in the human osteocalcin gene: Association with a nuclear proto-oncogene enhancer, J Biol Chem, 265, 21881, 10.1016/S0021-9258(18)45821-8

Noda, 1990, Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (Spp–1 or osteopontin) gene expression, Proc Natl Acad Sci USA, 87, 9995, 10.1073/pnas.87.24.9995

Cao, 1993, Cloning of the promoter for the avian integrin β3 subunit gene and its regulation by 1,25-dihydroxyvitamin D3, J Biol Chem, 268, 27371, 10.1016/S0021-9258(19)74259-8

Jurutka, 1994, Characterization of a new functional 1,25-dihydroxyvitamin D3 responsive element in the promoter region of the rat 25-hydroxyvitamin D3 24-hydroxylase gene, J Bone Miner Res, 9, S160 (abstract 157)

Zierold, 1994, Identification of a vitamin D-responsive element in the rat calcidiol (25-hydroxyvitamin D3) 24-hydroxylase gene, Proc Natl Acad Sci USA, 91, 900, 10.1073/pnas.91.3.900

Gill, 1993, Identification of sequence elements in mouse calbindin-D28K gene that confer 1,25-dihydroxyvitamin D3- and butyrate-inducible responses, Proc Natl Acad Sci USA, 90, 2984, 10.1073/pnas.90.7.2984

Liu, 1996, Characterization of a response element in the 5′-flanking region of the avian (chicken) PTH gene that mediates negative regulation of gene transcription by 1,25-dihydroxyvitamin D3 and binds the vitamin D3 receptor, Mol Endocrinol, 10, 206

Kim, 1996, Identification of a vitamin D3-response element that overlaps a unique inverted TATA box in the rat bone sialoprotein gene, Biochem J, 318, 219, 10.1042/bj3180219

Falzon, 1996, DNA sequences in the rat parathyroid hormone-related peptide gene responsible for 1,25-dihydroxyvitamin D3-mediated transcriptional repression, Mol Endocrinol, 10, 672

Kremer, 1996, Identification and characterization of 1,25-dihydroxyvitamin D3-responsive repressor sequences in the rat parathyroid hormone-related peptide gene, J Biol Chem, 271, 16310, 10.1074/jbc.271.27.16310

Tsonis, 1996, 9-cis retinoic acid antagonizes the stimulatory effect of 1,25 dihydroxyvitamin D3 on chrondrogenesis of chick limb bud mesenchymal cells: Interactions of their receptors, Int J Dev Biol, 40, 1053

Cheskis, 1994, Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers, Mol Cell Biol, 14, 3329

Thompson, 1998

Nakajima, 1996, All-trans and 9-cis retinoic acid enhance differentiation of U937 cells, Leuk Res, 20, 665, 10.1016/0145-2126(96)00020-3

Defacque, 1994, Different combinations of retinoids and vitamin D3 analogs efficiently promote growth inhibition and differentiation of myelomonocytic leukemia cell lines, J Pharmacol Exp Ther, 271, 193

Bunce, 1995, Treatment of HL60 cells with various combinations of retinoids and 1 alpha,25-dihydroxyvitamin D3 results in differentiation towards neutrophils or monocytes or a failure to differentiate and apoptosis, Leukemia, 9, 410

James, 1995, Vitamin D derivatives in combination with 9-cis retinoic acid promote active cell death in breast cancer cells, J Mol Endocrinol, 14, 391, 10.1677/jme.0.0140391

Kato, 1995, Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors, Mol Cell Biol, 15, 5858, 10.1128/MCB.15.11.5858

Kephart, 1996, Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast, Mol Endocrinol, 10, 408

Schräder, 1995, Natural vitamin D3 response elements formed by inverted palindromes: Polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation, Mol Cell Biol, 15, 1154, 10.1128/MCB.15.3.1154

Sneddon, 1997, DNA sequences downstream from the vitamin D response element of the rat osteocalcin gene are required for ligand-dependent transactivation, Mol Endocrinol, 11, 210, 10.1210/mend.11.2.9877

Ohyama, 1996, Functional assessment of two vitamin D-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase gene, J Biol Chem, 271, 30381, 10.1074/jbc.271.48.30381

Wheeler, 1995, Calreticulin inhibits vitamin D3 signal transduction, Nucleic Acids Res, 23, 3268, 10.1093/nar/23.16.3268

Kim, 1996, Association of 1α,25-dihydroxyvitamin D3-occupied vitamin D receptors with cellular membrane acceptance sites, Endocrinology, 137, 3649, 10.1210/endo.137.9.8756529

Imai, 1997, ERC-55, a binding protein for the papilloma virus E6 oncoprotein, specifically interacts with vitamin D receptor among nuclear receptors, Biochem Biophys Res Commun, 233, 765, 10.1006/bbrc.1997.6531

Schulman, 1996, Activation and repression by nuclear hormone receptors: Hormone modulates an equilibrium between active and repressive states, Mol Cell Biol, 16, 3807, 10.1128/MCB.16.7.3807

MacDonald, 1995, The vitamin D receptor interacts with general transcription factor IIB, J Biol Chem, 270, 4748, 10.1074/jbc.270.9.4748

Hong, 1997, GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors, Mol Cell Biol, 17, 2735, 10.1128/MCB.17.5.2735

Chen, 1997, Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300, Cell, 90, 569, 10.1016/S0092-8674(00)80516-4

Baudino, 1997, Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone, 320

Nakajima, 1997, A 65-kilodalton nuclear protein binds to the human vitamin D receptor: A bacterial-expressed histidine-tagged receptor study, Biochem Biophys Res Commun, 232, 806, 10.1006/bbrc.1997.6376

Le Douarin, 1995, The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18, EMBO J, 14, 2020, 10.1002/j.1460-2075.1995.tb07194.x

May, 1996, Human TAFII28 promotes transcriptional stimulation by activation function 2 of the retinoid X receptors, EMBO J, 15, 3093, 10.1002/j.1460-2075.1996.tb00672.x

Blanco, 1995, Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription, Proc Natl Acad Sci USA, 92, 1535, 10.1073/pnas.92.5.1535

Masuyama, 1997, The N-terminal domain of transcription factor IIB is required for direct interaction with the vitamin D receptor and participates in vitamin D-mediated transcription, Mol Endocrinol, 11, 218, 10.1210/mend.11.2.9879

Blanco, 1996, Inhibition of ligand induced promoter occupancy in vivo by a dominant negative RXR, Genes Cells, 1, 209, 10.1046/j.1365-2443.1996.d01-229.x